Dividendenkönig im Crash-Modus: Fallendes Messer oder Mega-Chance?

Die Aktie von Dividendenkönig Abbott Laboratories ist in den freien Fall übergangenen, der Chart ist schrecklich, doch Bewertung und Dividende umso attraktiver.

This website stores some user agent data. These data are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to opt-out of any future tracking, a cookie will be set up in your browser to remember this choice for one year. I Agree, Deny
642